STUDY OF THE IN-VITRO METABOLIC PROFILE OF AMLODIPINE IN HUMAN HEPATIC CELL LINE AND CHICKEN LIVER TISSUE USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY/MASS SPECTROMETRY

Authors

  • Divya Saxena Guru Nanak Institute of Research And Development, Guru Nanak Khalsa College, Mumbai
  • Shailesh Damale
  • Ajit Datar

Abstract

ABSTRACT
Objective: The main objective of this study was to investigate the in-vitro metabolic profile of Amlodipine (AMD) using normal human hepatic cell
lines and chicken liver tissue and to characterize the metabolites obtained using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Methods: In the present study, the metabolic profile of AMD, a well-known calcium channel blocker, was investigated in normal human hepatic cell
lines and chicken liver tissue employing LC-MS/MS technique. The structural details on AMD metabolites were acquired using triple quadrupole mass
spectrometer (LCMS-8040, Shimadzu). The metabolites were produced by incubation of AMD with the human hepatic cell lines and chicken liver
tissue at 37 °C for 24 h. The incubated extracts were analyzed on LC-MS/MS and their product ion spectra were acquired, interpreted and tentative
structures were proposed.
Results: Twelve Phase I and Phase II metabolites were successfully detected in the proposed study. The main metabolic changes observed were oxidative
deamination, N-acetylation, de-esterification, hydrogenation, de-methylation, aliphatic hydroxylation, and glucuronidation of dehydrogenated AMD.
Based on this information, the tentative structures of the metabolites were postulated.
Conclusion: The in-vitro metabolites of AMD were successfully investigated and characterized in human hepatic cell lines and chicken liver tissue.
Furthermore, both models were found to be equally effective for carrying out the in-vitro metabolic study of AMD.
Keywords: Amlodipine, Metabolites, Hepatic cell lines, Chicken liver tissue, Liquid chromatography, Liquid chromatography-mass spectrometry/
mass spectrometry.

Downloads

Download data is not yet available.

References

REFERENCES

Saxena D, Damale S, Joshi A, Datar A. Forced degradation studies

of amlodipine besylate and characterization of its major degradation

products by LC-MS/MS. Int J Life Sci Biotechnol Pharm Res

;3(3):196-207.

Tiwari RN, Shah N, Bhalani V, Mahajan A. LC, MS

and LC-MS/MS

studies for the characterization of degradation products of amlodipine.

J Pharm Anal 2015;5(1):33-42.

n

Rapolu R, Raju K, Srinivas K, Awasthi A, Navalgund SG,

Surendranath KV. Isolation and characterization of a novel acid

degradation impurity of Amlodipine Besylate using Q-TOF, NMR, IR

and single crystal X-ray. J Pharm Biomed Anal 2014;99:59-66.

Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin

Pharmacokinet 1992;22(1):22-31.

Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans.

Clin Pharmacokinet 1994;26(2):144-60.

Schonborn LJ. The Role of the Liver in Drug Metabolism. Anaesthesia

Tutorail of the Week 2010;179:1-6.

Prakash C, Shaffer CL, Nedderman A. Analytical strategies for

identifying drug metabolites. Mass Spectrom Rev 2007;26(3):340-69.

Oliveira EJ, Watson DG. Liquid chromatography-mass spectrometry in

the study of the metabolism of drugs and other xenobiotics. Biomed

Chromatogr 2000;14(6):351-72.

Brandon EF, Raap CD, Meijerman I, Beijnen JH, Schellens JH. An

update on in vitro test methods in human hepatic drug biotransformation

research: Pros and cons. Toxicol Appl Pharmacol 2003;189(3):233-46.

Maurel P. The use of adult human hepatocytes in primary culture and

other in vitro systems to investigate drug metabolism in man. Adv Drug

Deliv Rev 1996;22(1):105-32.

Fasinu P, Bouic PJ, Rosenkranz B. Liver-based in vitro technologies

for drug biotransformation studies - A review. Curr Drug Metab

;13(2):215-24.

Lv CM, Wei CM, Bu FL, Chen R, Wang XL, Li R, et al. Determination

of amlodipine in human plasma by LC-MS/MS and its bioequivalence

study in healthy chinese subjects. Pharmacol Pharm 2013;4(2):191-200.

Alsarra IA. High-performance liquid chromatographic method for

quantitative determination of amlodipine in human plasma and

pharmaceutical dosage form and its application to pharmacokinetic

studies. J Chromatogr Sci 2009;47(10):863-7.

Shimooka K, Sawada Y, Tatematsu H. Analysis of amlodipine in serum

by a sensitive high-performance liquid chromatographic method with

amperometric detection. J Pharm Biomed Anal 1989;7(11):1267-72.

Goyal RN, Bishnoi S. Voltammetric determination of amlodipine

besylate in human urine and pharmaceuticals. Bioelectrochemistry

;79(2):234-40.

Ma Y, Qin F, Sun X, Lu X, Li F. Determination and pharmacokinetic

study of amlodipine in human plasma by ultra-performance liquid

chromatography-electrospray ionization mass spectrometry. J Pharm

Biomed Anal 2007;43(4):1540-5.

Miks P, Maráková K, Marák J, Nemec I, Valásková IA, Havránek E.

Direct quantitative determination of amlodipine enantiomers in

urine samples for pharmacokinetic study using on-line coupled

isotachophoresis-capillary zone electrophoresis separation method with

diode array detection. J Chromatogr B Analyt Technol Biomed Life Sci

;875(1):266-72.

Yoo HH, Kim TK, Lee BY, Kim DH. Determination of S - and

R-amlodipine in rat plasma using LC-MS/MS after oral administration

of S - amlodipine and racemic amlodipine. Mass Spectrom Lett

;2(4):88-91.

Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, et al. Amlodipine

metabolism in human liver microsomes and roles of CYP3A4/5

in the dihydropyridine dehydrogenation. Drug Metab Dispos

;42(2):245-9.

Beresford AP, McGibney D, Humphrey MJ, Macrae PV, Stopher DA.

Metabolism and kinetics of amlodipine in man. Xenobiotica

;18(2):245-54.

Beresford AP, Macrae PV, Stopher DA. Metabolism of amlodipine in the

rat and the dog: A species difference. Xenobiotica 1988;18(2):169-82.

Stopher DA, Beresford AP, Macrae PV, Humphrey MJ. The metabolism

and pharmacokinetics of amlodipine in humans and animals. J

Cardiovasc Pharmacol 1988;12 Suppl 7:S55-9.

Beresford AP, Macrae PV, Alker D, Kobylecki RJ. Biotransformation of

amlodipine. Identification and synthesis of metabolites found in rat, dog

and human urine/confirmation of structures by gas chromatographymass

spectrometry and

liquid chromatography-mass

spectrometry.

Arzneimittelforschung

;39(2):201-9.

Suchanova B, Sispera L, Wsol V. Liquid chromatography-tandem mass

spectrometry in chiral study of amlodipine biotransformation in rat

hepatocytes. Anal Chim Acta 2006;573-574:273-83.

Suchanova B, Kostiainen R, Ketola RA. Characterization of the in vitro

metabolic profile of amlodipine in rat using liquid chromatographymass

spectrometry.

Eur J Pharm Sci 2008;33(1):91-9.

Published

01-07-2016

How to Cite

Saxena, D., S. Damale, and A. Datar. “STUDY OF THE IN-VITRO METABOLIC PROFILE OF AMLODIPINE IN HUMAN HEPATIC CELL LINE AND CHICKEN LIVER TISSUE USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY/MASS SPECTROMETRY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 365-71, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/12423.

Issue

Section

Original Article(s)